Corrigendum: Acquired CYP19A1 amplification is an early specific mechanism of aromatase inhibitor resistance in ERα metastatic breast cancer

Nat Genet. 2017 May 26;49(6):970. doi: 10.1038/ng0617-970b.
No abstract available

Publication types

  • Published Erratum